Updates on the Male Contraceptive ADAM in Clinical Trials
Biotech Company Claims Long-Lasting, Injectable Male Birth Control Lasts for at Least 2 Years
Things are heating up in the world of family planning with Contraline's ADAM making waves. This badass male contraceptive, a non-hormonal and reversible option, is kicking ass and taking names 24 months into its initial human clinical trial. The company has been low-key about it, but they're about to drop some hot, new data at the American Urological Association meeting on April 26.
In a nutshell, ADAM is a water-soluble hydrogel that gets injected into a man's vasa deferentia during a quickie procedure. It blocks the sperm while letting you shoot your shot, all without giving you hormonal crap or making a permanent change AKA vasectomy.
Alexander Pastuszak, Contraline's Chief Medical Officer, shared his excitement with the world, stating, "With these findings, we're stoked that ADAM's novel water-soluble hydrogel can last the intended two years. We're feeling optimistic about its safety, efficacy, and reversibility, and how it could give men and couples more control over their baby-making game."
So, what's the deal with those two participants reaching azoospermia (the absence of sperm in their ejaculate) at 24 months? Well, it means the testosterone world Music City style! In a previous announcement, Contraline hyped up ADAM's ability to reduce the number of active sperms by 99.8% to 100% within 30 days of implantation.
All these results represent a massive step forward in transforming the contraceptive landscape, according to Contraline's CEO, Kevin Eisenfrats. "It's cool to think that we're approaching efficacy levels comparable to long-lasting female contraceptives like IUDs," he said. "If ADAM does turn out to be a safe bet, we believe it could become the go-to choice for men when it comes to contraception."
Sounds like a slam dunk, right? Well, Jon Oatley, a genius at Washington State University's School of Molecular Biosciences, has raised some concerns. There ain't no solid proof that the ADAM implant can be undone, and we still don't know the long-term impact of messing with the vasa deferentia. Oatley also hinted that most men might prefer a pill or patch over surgery.
On a more positive note, data from 2017 to 2019 shows that about 10.4% of ladies between ages 15 and 49 used long-acting reversible contraceptives (LARCs), like IUDs or other implants. That's less than four points behind the pill's 14%. If ADAM proves to be a reliable choice, then a significant number of men might go for the extended protection offered by an injection instead of short-term options.
Fingers crossed for this disruptive, non-hormonal, long-lasting, reversible male contraceptive. It's about time men had more say in the baby-making business. Stay tuned for more updates!
- The advancements in science and technology are making strides in the field of health, as evident in the development of Contraline's ADAM, a novel male contrceptive.
- Gizmodo reports that ADAM, a water-soluble hydrogel, is currently being tested in clinical trials and has shown promising results in maintaining its effectiveness for two years.
- In the realm of health-and-wellness, the potential for ADAM to provide men with a non-hormonal, long-lasting, and reversible contraceptive option could revolutionize the future of sexual health and men's health.
- While scientists remain optimistic about the potential of ADAM, concerns have been raised about its long-term effects and the potential for reversibility, as explored in the field of molecular biosciences.
